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A B S T R A C T
The European DNA Proﬁling Group (EDNAP) organized a fourth and ﬁfth collaborative exercise on RNA/
DNA co-analysis for body ﬂuid identiﬁcation and STR proﬁling. The task was to identify dried menstrual
blood and vaginal secretion stains using speciﬁc RNA biomarkers, and additionally test 3 housekeeping
genes for their suitability as reference genes. Six menstrual blood and six vaginal secretion stains, two
dilution series (1/4–1/64 pieces of a menstrual blood/vaginal swab) and, optionally, bona ﬁde or mock
casework samples of human or non-human origin were analyzed by 24 participating laboratories, using
RNA extraction or RNA/DNA co-extraction methods. Two novel menstrual blood mRNA multiplexes were
used: MMP triplex (MMP7, MMP10, MMP11) and MB triplex (MSX1, LEFTY2, SFRP4) in conjunction with a
housekeeping gene triplex (B2M, UBC, UCE). Two novel mRNA multiplexes and a HBD1 singleplex were
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C. Haas et al. / Forensic Science International: Genetics 8 (2014) 203–212204used for the identiﬁcation of vaginal secretion: Vag triplex (MYOZ1, CYP2B7P1 and MUC4) and a
Lactobacillus-speciﬁc Lacto triplex (Ljen, Lcris, Lgas). The laboratories used different chemistries and
instrumentation and all were able to successfully isolate and detect mRNA in dried stains. The
simultaneous extraction of RNA and DNA allowed for positive identiﬁcation of the tissue/ﬂuid source of
origin by mRNA proﬁling as well as a simultaneous identiﬁcation of the body ﬂuid donor by STR proﬁling,
also from old and compromised casework samples. The results of this and the previous collaborative RNA
exercises support RNA proﬁling as a reliable body ﬂuid identiﬁcation method that can easily be
combined with current STR typing technology.
 2013 Elsevier Ireland Ltd. All rights reserved.
Housekeeping genes
mRNA proﬁling1. Introduction
Conventional tests for the identiﬁcation of blood, saliva and
semen are based on enzymatic and immunological reactions of cell
speciﬁc enzymes and antigens, but many of these tests lack
speciﬁcity [1]. Recently two screening tests for the identiﬁcation of
menstrual blood were described, that utilize antibodies for ﬁbrin–
ﬁbrinogen degradation products (latex agglutination test, D-dimer
assay) [2,3]. Neither test has been conﬁrmed and validated for
forensic use. Up to now no reliable presumptive test for the
identiﬁcation of vaginal secretion exists [1]. The analysis of cell-
speciﬁc mRNA expression is a conﬁrmative method for the
identiﬁcation of body ﬂuids [1,4–37]. The suitability of mRNA
proﬁling assays has also been demonstrated for old and
environmentally compromised samples [17,18,35]. Recently, three
collaborative exercises were performed by the European DNA
Proﬁling Group (EDNAP – http://www.isfg.org/EDNAP) in order to
evaluate the robustness and reproducibility of mRNA proﬁling for
blood, saliva and semen identiﬁcation: (1) evaluation of three
blood-speciﬁc markers (HBB, SPTB and PBGD) using singleplex
reactions [38]; (2) evaluation of seven blood-speciﬁc markers
using two multiplex systems, a ‘high sensitivity’ duplex (HBB, HBA)
and a ‘moderate sensitivity’ pentaplex (ALAS2, CD3G, ANK1, PBGD
and SPTB) [39] and (3) a saliva triplex including the markers HTN3,
STATH and MUC7 and a semen pentaplex allowing the detection
and differentiation of sperm (PRM1, PRM2) and seminal plasma
(PSA, SEMG1 and TGM4), the latter of which is necessary for the
identiﬁcation of semen from azoospermic men [40]. Most
laboratories, some of which had no prior experience with RNA,
were able to successfully isolate and analyze RNA from theTable 1
List of evaluated mRNA markers for the identiﬁcation of vaginal secretion, menstrual b
Gene
Menstrual Blood
MMP7 matrix metalloproteinase  7
MMP10 matrix metalloproteinase 10
MMP11 matrix metalloproteinase 11
MSX1 msh homeobox  1
LEFTY2 left-right determination factor  2
SFRP4 secreted frizzled-related protein  4
Hs202072* uncharacterized LOC100505776
Vaginal secretion
MYOZ1 myozenin-1
CYP2B7P1 cytochromeP450, family 2, subfamily B,
polypeptide 7 pseudogene 1
MUC4 mucin  4
HBD1 human beta-defensin 1
Ljen Ljen [16s ribosomal RNA]
Lcris Lcris [16S-23S intergenic spacer region ]
Lgas Lgas [16S-23S intergenic spacer region]
Housekeeping genes
B2M Beta-2 microglobulin
UBC Ubiquitin C
UCE Ubiquitin conjugating enzyme
MMP triplex
MB triplex
Vag triplex
HBD1 singleplex
Lacto triplex
HKG triplex
*Not sensitive.provided samples. While sensitivity varied between laboratories,
the method proved to be reproducible and sensitive using different
analytical strategies.
A fourth and ﬁfth collaborative exercise was organized by the
Institute of Legal Medicine, University of Zu¨rich, Switzerland, on
behalf of EDNAP in order to test forensically suitable menstrual
blood and vaginal secretion markers, respectively. In addition 3
housekeeping genes were evaluated. In a preliminary study
performed by the Florida and Zu¨rich laboratories, various menstrual
blood and vaginal secretion mRNA markers described in the
literature [11,19,23,34,36] were evaluated in terms of sensitivity,
speciﬁcity and performance with casework samples. For this study, 7
menstrual blood, 7 vaginal secretion and 3 housekeeping gene
markers were tested, 16 of which were deemed most suitable for
forensic use (Table 1). Hs202072 was seldom detectable during pre-
testing and therefore excluded from further analysis. In these
exercises, the following multiplexes were developed and provided
to the participating laboratories: (1) two menstrual blood multi-
plexes, MMP triplex (MMP7, MMP10, MMP11) and MB triplex
(MSX1, LEFTY2, SFRP4) in conjunction with a housekeeping gene
triplex (B2M, UBC, UCE); (2) two vaginal secretion triplexes,
including human Vag triplex (MYOZ1, CYP2B7P1 and MUC4) and
bacterial Lacto triplex (Ljen, Lcris, Lgas) and a HBD1 singleplex. These
multiplexes were developed for ease of use in the exercises and have
not been validated for routine use.
The exercises included the analysis of mock casework samples
(2  8), dilution series of menstrual blood and vaginal secretions
and optional additional bona ﬁde or mock casework samples from
the participating laboratories. The housekeeping gene markers
were included in order to evaluate their use as positive controls forlood and housekeeping genes.
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The expression of these housekeeping genes was additionally
tested in blood, saliva and semen dilution series. Several
housekeeping gene markers have already been tested on body
ﬂuids [19,24,32,37], but up to now, no marker has been described
that is universally suitable for all body ﬂuids. Saliva and semen
normally show reduced expression of housekeeping genes,
probably because spermatozoids contain little cytoplasm and
few ribosomes and the desquamated cells of the buccal mucosa
have almost no cell metabolism [19].
Here we present data from 20 and 23 laboratories participating
in the fourth and ﬁfth collaborative exercise on the identiﬁcation of
menstrual blood and vaginal secretion respectively.
2. Materials and methods
2.1. Samples and materials provided
The organizing laboratory (Institute of Legal Medicine, Univer-
sity of Zu¨rich, Switzerland) sent one set of samples for each
exercise to the participating laboratories.
Exercise 4 included stains 1–8 (menstrual blood, non-menstru-
al blood, Table 2), a menstrual blood dilution series (1/4–1/64 of a
menstrual blood swab) and 3 dilution series of blood, semen and
saliva (1–0.001 ml blood, 5–0.04 ml semen, 25–0.2 ml saliva).
Menstrual blood from 6 different donors (for 6 stains and 1 dilution
series) was collected on swabs or on sanitary towels (4 fresh
samples and 3 that had been stored for up to 5 years at room
temperature in the dark). Additional fresh samples not containing
menstrual blood (blood, saliva, vaginal secretion) were provided by
3 female donors. Semen (stored frozen for 5 years, thawed and
placed on swabs) was provided by 1 male donor. For stain 2, a
quarter of a swab containing 40 ml EDTA-blood (corresponds to
about 10 ml blood per stain) was provided. Stain 5 was a quarter of
a vaginal secretion swab. For the blood, semen and saliva dilution
series, samples were diluted in 0.9% NaCl to a ﬁnal volume of 5 ml
per sample and placed on swabs.
Exercise 5 included stains 9–16 (vaginal secretion, non-vaginal
secretion, Table 2) and a vaginal secretion dilution series (1/4–1/
64 of a vaginal secretion swab). Vaginal secretion from 6 differentTable 2
mRNA proﬁling results (MMP, MB, HKG, Vag, Lacto triplexes and HBD1 singleplex) from
were detected by more than half of the laboratories, light grey squares are stains/mark
stains/markers that were detected by <25% of the laboratories.
MMP triplex 
Stain Sample MMP11 MMP7 
1 Menstrual blood on sanitary towel (fresh) 19/20 18/20 
3 1/4 menstrual blood swab (fresh) 20/20 19/20 
4 Menstrual blood on sanitary towel (5 year old) 19/20 12/20 
6 1/4 menstrual blood swab (5 year old, d1–4) 17/20 16/20 
7 1/12 menstrual blood swab (5 year old, d1/d4) 9/20 7/20 
8 1/4 menstrual blood swab (fresh) 4/20 9/20 
5 1/4 vaginal swab (fresh) 1/20 10/20 
2 1/4 swab with EDTA-blood (fresh) 5/20 1/20 
Vag triplex 
Stain Sample MYOZ1 CY
9 1/4 vaginal swab (2 year old) 22/22 22
10 5  5 mm from white worn underpant (fresh) 9/22 18
12 1/2 vaginal swab, pregnant (fresh) 21/22 21
13 1/4 vaginal swab (5 year old) 20/22 19
14 1/2 vaginal swab (fresh) 22/23 22
16 5  5 mm from sanitary towel (fresh) 1/23 5/2
15 1/2 buccal swab (fresh) 6/23 2/2
11 1/2 swab urine (fresh) 0/22 2/2donors (for 6 stains and 1 dilution series) was collected on swabs,
on a sanitary towel or in underpants, 5 of them were fresh and 2
had been stored for up to 5 years at room temperature in the dark.
Fresh non-vaginal secretion samples (urine, saliva) were provided
by 2 female donors. Stain 11 was half of a swab that was immersed
into liquid urine and stain 15 was half of a buccal swab.
In both exercises, the laboratories were asked, but not required,
to examine additional samples: (1) bona ﬁde or mock casework
material that could include human and/or non-human menstrual
blood and vaginal secretion stains or (2) other forensically relevant
body ﬂuids (e.g. blood, semen, saliva).
HPLC-puriﬁed primers were purchased from Microsynth (St.
Gallen, Switzerland). The organizing laboratory prepared primer
mixes for the multiplexes and aliquots were provided to the
participating laboratories for use in ampliﬁcation reactions (see
below). The primers and samples were sent non-refrigerated by
Fedex or DHL (exercise 4, arrival within 1–2 days, except 1 parcel
that was 20 days in transit; exercise 5, arrival within 1–3 days,
except 2 parcels that were 8 and 10 days in transit).
2.1.1. RNA(/DNA co-)extraction and reverse transcription
The participating laboratories were asked to use the entire swab
or stain for extraction (RNA only or RNA/DNA co-extraction). The
organizing laboratory provided an example protocol for extraction
and reverse transcription. The laboratories could, however, use
methods of their own choice. The example protocols were
described previously [38,39].
2.1.2. RNA- and DNA-quantiﬁcation
Participating laboratories were asked to quantify RNA using one
of the following methods: Quant-iTTM RiboGreen1 RNA Assay kit
(Invitrogen) using a ﬂuorescence microplate reader (high and low
range protocol option) [11], Quant-iTTM RNA assay kit (Invitrogen)
using the Qubit ﬂuorometer [26] or Bioanalyzer (Agilent) [20].
Laboratories were able to quantify DNA using a quantiﬁcation
system of their own choice.
2.2. Endpoint PCR
The primer sets and amplicon lengths are shown in Table S1.
The forward primers of the menstrual blood and vaginal secretion 24 laboratories for the 16 stains. Dark grey squares represent stains/markers that
ers that were detected by 25–50% of the laboratories and white squares represent
MB triplex HKG triplex
MMP10 MSX1 LEFTY2 SFRP4 B2M UBC UCE
20/20 10/20 20/20 3/20 20/20 20/20 19/20
18/20 18/20 16/20 15/20 20/20 20/20 20/20
20/20 8/20 19/20 3/20 20/20 19/20 17/20
18/20 11/20 7/20 8/20 20/20 20/20 18/20
8/20 11/20 6/20 2/20 18/20 18/20 13/20
11/20 2/20 0/20 0/20 20/20 20/20 20/20
4/20 12/20 1/20 0/20 20/20 20/20 20/20
1/20 0/20 0/20 0/20 20/20 20/20 19/20
Lacto triplex Singleplex
P MUC4 Ljen Lcris Lgas HBD1
/22 22/22 10/22 19/22 1/22 21/22
/22 15/22 22/22 17/22 7/22 6/22
/22 22/22 8/22 3/22 22/22 21/22
/22 20/22 19/22 19/22 1/22 20/22
/23 22/23 23/23 2/23 21/23 20/23
3 2/23 13/23 0/23 1/23 7/23
3 7/23 17/23 3/23 2/23 7/23
2 8/22 21/22 1/22 6/22 9/22
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50-labeled with the NED-analogue ATTO550.
The following ampliﬁcation conditions were recommended:
MMP, MB, HKG, Vag, Lacto triplexes: The 25 ml reaction mix
contained 2 ml cDNA, 2.5 ml 10 primer mix (see below), 12.5 ml
2 Multiplex PCR Mastermix (Multiplex PCR kit, QIAGEN), 2.5 ml
Q-Solution (Multiplex PCR kit; QIAGEN), 5.5 ml H2O. HBD1
singleplex: The 25 ml reaction mix contained 5 ml cDNA, 2.5 ml
10 PCR Buffer II, 2.5 ml dNTPs (2.5 mM each), 3 ml MgCl2
(25 mM), 2 ml 12.5 primer mix, 0.4 ml AmpliTaq Gold1 (5 U/
ml) and 9.6 ml H2O (all singleplex reagents from Life Technolo-
gies). Sterile water was used in place of cDNA for no-template
controls.
The 10 primer mixes were prepared using the following
concentrations: MMP triplex: 2 mM each; MB triplex: MSX1 5 mM,
SFRP4 5 mM, LEFTY2 2 mM; Vag triplex: 2 mM each; Lacto triplex:
2 mM each; HKG triplex: B2M 2 mM, UBC 2 mM, UCE 5 mM. The
12.5 primer mix for the HBD1 singleplex was 20 mM.
The cycling conditions were as follows: MMP, MB, HKG, Vag,
Lacto triplexes: the initial denaturation was at 95 8C for 15 min,
followed by 35 cycles of 94 8C 30 s, 55 8C (+0.2 8C per cycle) 90 s,
72 8C 40 s and ﬁnal elongation at 72 8C for 30 min; HBD1 singleplex:
The initial denaturation was at 95 8C for 11 min, followed by 35
cycles of 94 8C 20 s, 55 8C 60 s, 72 8C 45 s and ﬁnal elongation at
72 8C for 30 min.
Post PCR puriﬁcation was optional, but recommended, to
eliminate dye blobs and to concentrate/dilute the samples by
variation of the elution volume (e.g. MinElute PCR puriﬁcation kit,
QIAGEN) [26,41].
2.2.1. Capillary electrophoresis (CE)
The participating laboratories used standard, multi-color
ﬂuorescent genetic analyzers and standard electrophoresis con-
ditions for the detection of the menstrual blood, vaginal secretion
and housekeeping gene speciﬁc amplicons (Table S2). Any dye set
that included FAM and NED, with associated internal lane
standard, could be used. Raw data were analyzed with GeneScan1
or Genemapper1 Software (Life Technologies). For data compila-
tion, the threshold for a positive result was set to 100 RFUs (relative
ﬂuorescence units) or 200 RFUs (Genetic Analyzer 3500 series)
respectively, for consistency between laboratories and to avoid
inclusion of false positive results (due to the presence of dye blobs
and baseline noise).
2.2.2. DNA-ampliﬁcation and -detection
If DNA was co-extracted, the laboratories were asked to use a
standard STR typing kit, PCR and CE conditions of their choice
(Table S2). A peak detection threshold of 50 RFUs was used.
3. Results
Laboratories 1–20 participated in exercise 4 and laboratories 1–
9, 11–24 participated in exercise 5. Each laboratory was asked to
complete a questionnaire describing the methods used (Table S2).
The 24 laboratories used 6 different kits for RNA only or RNA/DNA
co-extraction, 6 different reverse transcription kits, 9 different STR
typing kits for DNA analysis, 7 different thermocyclers, 4 different
genetic analyzers and 3 different polymers (Table S2). Since 3
packages experienced longer shipping times at outside/room
temperature, primer mixes may have been impaired. Slightly
reduced sensitivities were reported with the vaginal markers (8
and 10 days in transit), but no impairment was detected with the
menstrual blood multiplexes (20 days in transit). Since no
signiﬁcant adverse effects were observed (slight reduction in
sensitivity could be due to other contributing factors as well),
results from these laboratories were included in the ﬁnal analysis.While unfortunate, the delays have provided some useful
information regarding the robustness of the consumables and
mRNA.
3.1. RNA results
The mRNA proﬁling results are summarized in Table 2. All 24
laboratories were able to perform the method successfully as
demonstrated by detection of the RNA menstrual blood, vaginal
secretion and housekeeping gene markers. No results for stains 9–
13 were available for laboratory 7 due to incorrect manipulation of
the stains, but results were obtained for all other samples in the
exercises.
The 6 menstrual blood and 6 vaginal secretion stains were
identiﬁed correctly by all laboratories (Table 2). The MMPs, MSX1
and LEFTY2 were detected in most menstrual blood samples
(stains 1, 3–4, 6–8) by more than half of the laboratories, but SFRP4
was only detected in the high input menstrual blood samples 3 and
6. MYOZ1, CYP2B7P1, MUC4, HBD1 and at least one of the
lactobacilli markers were reliably detected in the vaginal secretion
samples (stains 9–10, 12–14, 16). Stains 8 (1/4 fresh menstrual
blood swab) and 16 (5  5 mm from fresh sanitary towel) appeared
to be challenging possibly due to donor speciﬁc light menstrual
blood/vaginal secretion ﬂow.
For stain 6, menstrual blood swabs were collected from the
same donor on days 1–4 of menstruation, for stain 7 from another
donor on days 1 and 4, all stored 5 years at room temperature in
the dark. Several laboratories were given part of the same
menstrual blood swab for analysis. We then evaluated the
variation in marker detection amongst the samples from days
1–4 (Table S3). By day 3 and day 4 of menstruation some of the
menstrual blood speciﬁc markers (MSX1, LEFTY2, SFRP4) tended
to disappear, whereas the metalloproteinase markers (MMP7,
MMP10, MMP11) were detected for most of the days of
menstruation, with some (possible intra-individual) variation.
Variation in gene expression is expected over the reported days of
menstruation, especially towards the end of menstruation, as
menstrual blood ﬂow can vary signiﬁcantly [42]. For stain 13,
vaginal swabs were collected from the same donor on days 5, 7, 13,
20, 24 and 28 of the menstrual cycle (stored 5 years at room
temperature in the dark). Some laboratories were given a quarter
of the same vaginal swab for analysis (in one instance, 3 labs using
one of the samples and 4 labs using another). The results were
similar for all time points and markers and are therefore collated
into one result (Table 2, stain 13). Representative electropher-
ograms of menstrual blood and vaginal secretion stains are shown
in Figs. 1 and 2.
In exercise 4, two non-menstrual blood samples (stain 2:
blood; stain 5: vaginal secretion) and in exercise 5, two non-
vaginal secretion samples (stain 11: urine; stain 15: saliva) were
included in order to evaluate the speciﬁcity of the included
menstrual blood and vaginal secretion markers. MMP7 and MSX1
were detected by more than half of the laboratories in stain 5 (1/4
vaginal swab), and MUC4, HBD1, MYOZ1, Ljen and Lgas were
detected in stains 11 (1/2 urine swab) and 15 (1/2 buccal swab).
Minor occurrences of cross reactivity were observed for the other
markers by a small number of laboratories (Table 2). In general,
the cross reactive peaks showed reduced signal intensities
compared to those of menstrual blood and vaginal secretion
samples (Table S4).
For the dilution series, the HKG 3plex markers were detected
by most laboratories down to the smallest sample size (1/64
menstrual swab) (Table 3). The MMP markers, whereof MMP10
was the most sensitive, were detected by more than half of the
laboratories down to the smallest sample size. MSX1 was
detected by more than half of the laboratories in 1/8-sized
Fig. 1. Representative electropherograms from a menstrual blood sample (stain 3, 1/4 fresh menstrual blood swab, laboratory 15). RNA was analyzed with the MMP triplex (a),
the MB triplex (b) and the HKG triplex (c). DNA was analyzed with the SGMplus kit (d). Overﬂow peaks are marked with an asterisk (*).
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LEFTY2 and SFRP4 were the least sensitive markers and were
detected only by a few laboratories (even in high input samples).
MYOZ1, CYP2B7P1, MUC4, HBD1, Ljen and Lcris were alsodetected by most laboratories down to the smallest sample size
(1/64 vaginal swab) (Table 3). Lgas was only sporadically
detected throughout the range of sample sizes tested, which
might be due to the limited co-presence of different Lactobacilli
Fig. 2. Representative electropherograms from a vaginal secretion sample (stain 13, 1/4 vaginal swab (5 year old), laboratory 17). RNA was analyzed with the Vag triplex (a),
the Lacto triplex (b) and the HBD1 singleplex (c). DNA was analyzed with the NGM kit (d). Overﬂow peaks are marked with an asterisk (*).
C. Haas et al. / Forensic Science International: Genetics 8 (2014) 203–212208within one individual (see Section 4) rather than the detection
sensitivity per se of the marker.
Only sporadic peaks were detected in the RT minus (no
reverse transcriptase added) or PCR negative controls (data notshown). In exercise 5, eight laboratories detected 1, 2 or all 3
Lacto markers in RT minus controls. In most, but not all, cases
the peaks in the RT minus controls were considerably smaller
than the respective peaks in the RT plus samples. Additionally,
Table 3
mRNA proﬁling results (MMP, MB, HKG, Vag, Lacto triplexes and HBD1 singleplex) from 24 laboratories for the menstrual blood and vaginal secretion dilution series. Dark
grey squares represent stains/markers that were detected by more than half of the laboratories, light grey squares are stains/markers that were detected by 25–50% of the
laboratories and white squares represent stains/markers that were detected by <25% of the laboratories.
MMP triplex MB triplex HKG triplex
Sample MMP11 MMP7 MMP10 MSX1 LEFTY2 SFRP4 B2M UBC UCE
1/4 15/20 16/20 19/20 11/20 7/20 3/20 20/20 20/20 20/20
1/8 14/20 13/20 18/20 12/20 4/20 6/20 20/20 20/20 20/20
1/16 13/20 15/20 17/20 10/20 4/20 2/20 20/20 19/20 20/20
1/32 12/20 9/20 17/20 3/20 3/20 3/20 20/20 20/20 19/20
1/64 7/20 9/20 14/20 3/20 4/20 3/20 19/20 19/20 15/20
Vag triplex Lacto triplex Singleplex
Sample MYOZ1 CYP MUC4 Ljen Lcris Lgas HBD1
1/4 23/23 23/23 23/23 22/23 21/23 2/23 22/23
1/8 22/23 22/23 21/23 22/23 21/23 2/23 19/23
1/16 21/23 21/23 20/23 21/23 21/23 2/23 16/23
1/32 19/23 21/23 20/23 21/23 19/23 2/23 14/23
1/64 15/23 19/23 19/23 20/23 18/23 4/23 12/23
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laboratories.
Only two laboratories in exercise 4 and four laboratories in
exercise 5 quantiﬁed the RNA: One used the Quant-iTTM RNA assay
kit as well as the Bioanalyzer; one used the Quant-iTTM Ribo-
Green1 RNA Assay kit and two used a Nanodrop microvolume
spectrophotometer (Table S5). Despite the small stain sizes and the
different quantiﬁcation methods, the RNA quantiﬁcation results
correlated quite well, in that the body ﬂuid dilution series showed
decreasing RNA amounts and high/low level stains could be
differentiated (Table S5). Since only a small number of laboratories
performed RNA quantitation, there was insufﬁcient data in order to
determine the correlation (if any) between the quantiﬁcation
result and RNA proﬁling success.
Post-PCR puriﬁcation resulted in increased peak heights and
reduced baseline signal noise but did not allow for detection of
additional markers that were not observed prior to post-PCR
puriﬁcation. Eight laboratories in exercise 4 and 7 laboratories in
exercise 5 performed post-PCR puriﬁcation.
3.1.1. Comparison to other multiplexes
Two laboratories additionally tested the extracted RNA/cDNA
with their own body ﬂuid speciﬁc multiplexes, a 19plex from NFI
[32] in EDNAP RNA exercise 4 and the CellTyper 11plex from ESR
[23,24] in EDNAP RNA exercise 5. The 19plex includes the 2
menstrual secretion markers MMP7 and MMP11 with different
primer sets than used in the MMP 3plex. The 19plex and the MMP
3plex results were difﬁcult to compare, because different cDNA
dilutions, PCR cycle numbers and CE injection voltage/time were
applied (19plex data not shown). However, the menstrual blood
stains and menstrual blood dilution series were identiﬁed correctly
with both multiplexes. Additionally, the 19plex provided indica-
tions for stains 2 and 5 to be blood and vaginal secretion and also
identiﬁed the body ﬂuid dilution series as blood, saliva and semen.
The CellTyper 11plex includes the 2 vaginal markers Lcris and Lgas
with different primer sets than used in the Lacto 3plex. The results
of the CellTyper 11plex (data not shown) and Lacto 3plex were in
good agreement for stains 9–16 and the vaginal secretion dilution
series. Additionally, the CellTyper 11plex identiﬁed stain 15
successfully as saliva.
3.2. DNA results
A total of 19 and 22 laboratories (exercise 4 and 5,
respectively) performed RNA/DNA co-extraction. No speciﬁca-
tion for DNA analysis was provided. Various STR typing kits andcycle numbers were utilized by the participating laboratories
(Table S2). Full STR proﬁles were obtained from all stains and the
menstrual blood/vaginal secretion dilution series (down to the
1/64 swab) by most laboratories (data not shown). The obtained
genotypes were conﬁrmed by comparison with reference
proﬁles. A total of 15 and 19 laboratories (exercise 4 and 5,
respectively) quantiﬁed the DNA using different quantiﬁcation
systems. Due to the small stain sizes and the different extraction
and quantiﬁcation methods used, the DNA quantiﬁcation results
were difﬁcult to compare. However, the results were in the same
order of magnitude for each particular stain (Table S6). Overall,
the results demonstrated that DNA of sufﬁcient quantity and
quality for STR analysis could be simultaneously extracted with
RNA from small amounts of dried stains.
3.2.1. RNA and DNA results of the blood/semen/saliva dilution series
Dilution series of blood (1–0.001 ml), semen (5–0.04 ml) and
saliva (25–0.2 ml) were tested with the HKG triplex to test these
housekeeping genes for their suitability as positive control for the
presence of biological material and for successful RNA extraction/
reverse transcription. These body ﬂuid dilution series were
prepared in such a way that loss of the housekeeping gene
markers by dilution could be observed. Since saliva and semen are
known to exhibit reduced housekeeping gene activity, higher input
amounts of saliva and semen were used. Most laboratories
performed RNA/DNA co-extraction on these samples and could
provide RNA and DNA results. Some of these housekeeping genes
could be detected down to 0.01 ml blood, 0.2 ml semen and 1 ml
saliva (Table S7). Based on these dilution series, B2M and UBC
seemed to be more sensitive than UCE for all tested body ﬂuids. STR
proﬁles could be recovered down to about the same amounts,
except for semen where partial proﬁles down to 0.04 ml were
reported (Table S7). On the other hand good RNA results (B2M and
UBC) could be obtained from 0.01 ml blood, whereas poor STR
results were obtained from this same amount of blood.
3.2.2. RNA and DNA results of the optional stain samples
The laboratories were invited to analyze additional samples
including bona ﬁde and mock casework samples, non-menstrual
blood, non-vaginal secretion and non-human samples. Forty-nine
menstrual blood samples, 28 non-menstrual blood samples (blood,
saliva, semen, urine, vaginal secretion, skin) and 5 non-human
samples (cat, dog, chimpanzee) were tested by 12 laboratories
with the menstrual blood multiplexes. Fifty-ﬁve vaginal samples,
12 menstrual blood, 52 non-vaginal samples (blood, saliva, semen,
skin, anal) and 2 non-human samples (cat, dog) were tested by 16
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least one of the speciﬁc markers was detectable in almost all
menstrual blood and vaginal secretion stains (Tables S7 and S8),
including various stain sizes, storage periods and storage condi-
tions. Vaginal markers were also detected in menstrual blood
stains as is expected since menstrual blood is a complex mixture of
menstrual blood, peripheral blood and vaginal secretions. For the
menstrual blood stains, only one sample showed no RNA result at
all (body ﬂuid speciﬁc markers and housekeeping genes), perhaps
due to limited cell amount, but a DNA proﬁle could be generated.
For two other menstrual blood stains housekeeping genes were
detected, but no body ﬂuid speciﬁc marker. This may be attributed
to the presence of a limited amount of actual menstrual blood in
the sample but sufﬁcient biological material (e.g. vaginal secretion)
present to permit detection of the housekeeping genes. Two
vaginal secretion stains were negative for vaginal speciﬁc markers:
One endovaginal swab from a 13 year old girl and another speciﬁed
as underwear from a man in a rape case. In the latter case the
presence of the stain being from this source might be uncertain or
not enough female cell material was present.
Sporadic cross reactive peaks (most of them <1000 RFUs) were
observed with the menstrual blood markers in blood, saliva, semen
and more prominently in a skin sample (described as ‘human skin
wound’) and several vaginal swabs (not speciﬁed at which day of
cycle) (Table S8). The 3 housekeeping genes performed well in all
human stains tested, only UCE appeared to perform less well in
saliva samples (Table S8). Only sporadic peaks were observed with
the vaginal markers in blood and skin, but several cross reactive
peaks in saliva and semen were observed (mainly from Ljen) (Table
S9). Full autosomal STR proﬁles were obtained for most samples
where an RNA/DNA co-extraction was performed (data not
shown).
4. Discussion
The purpose of this exercise was to evaluate an RNA/DNA co-
extraction strategy with challenging menstrual blood and vaginal
secretion samples and novel menstrual blood- and vaginal
secretion-speciﬁc mRNA multiplexes (2 menstrual blood triplexes
including the markers MMP7, MMP10, MMP11, MSX1, LEFTY2,
SFRP4 as well as 2 vaginal secretion triplexes including the markers
MYOZ1, CYP2B7P1, MUC4, Ljen, Lcris, Lgas) and a HBD1 singleplex.
In addition, a housekeeping gene triplex (B2M, UBC, UCE) was
tested to conﬁrm the presence of RNA of sufﬁcient quantity and
quality for analysis. Co-extracted DNA was analyzed with various
commercial STR typing kits.
All participating laboratories successfully applied the method
using their own laboratory equipment and different kits and
chemicals for RNA only or RNA/DNA co-extraction, reverse
transcription and PCR. The samples to be analyzed in this exercise
were challenging because the laboratories did not know the tissue
origin and some stains were low template samples. The differing
sensitivities between the laboratories can be explained by the
different extraction kits and reverse transcription chemistries
used. In addition, it is not possible to prepare identical stains for so
many laboratories, different swabs and even different parts from
the same swab can contain different cell amounts. And some
packages experienced longer transit times at outside/room
temperature, which could have impaired the primer mixes.
The evaluated menstrual blood markers proved to be speciﬁc,
apart from single positive reactions with non-menstrual blood
stains (mainly vaginal secretion). Towards the end of menstrua-
tion, as menstrual blood ﬂow can be signiﬁcantly lighter, some of
the menstrual blood speciﬁc markers (MSX1, LEFTY2, SFRP4)
tended to disappear, whereas the metalloproteinase markers were
detected for most days of menstruation. We could not conﬁrm thereported reduced expression of MMP11 on day 1 [5], which might
be due to the time point of sample taking and inter-individual
differences. Amongst the menstrual blood markers, the metallo-
proteinase markers exhibited the highest sensitivity with more
than half of the laboratories detecting all three markers with as
little as 1/16 of a swab and MMP10 detected by more than half of
the laboratories with as little as 1/64 swab. The sensitivity for
MSX1, LEFTY2 and SFRP4, was considerably lower than those
observed for the metalloproteinase markers. MSX1 was detected
by more than half of the laboratories down to 1/16 of a swab, while
LEFTY2 and SFRP4 were not detected by more than half of the
laboratories for any of the sample sizes.
All of the evaluated vaginal secretion markers were able to
detect vaginal secretion. However, MUC4 and HBD1 cross-reacted
with other body ﬂuids (mainly saliva) as has been reported
previously [12,21,37,43]. It was reported that predominance of one
Lactobacillus species is common in vaginal microbial populations
[44,45]. In particular, 4 species of this genus (L. iners, L. crispatus, L.
gasseri, L. jensenii) are mainly represented in women from different
regions and ethnic groups with very limited evidence of their co-
presence in the same host [44,45]. The results from this study
appear to support that ﬁnding in that most vaginal samples
exhibited only one of the 2 species Lcris or Lgas. Ljen was detected
in the majority of the samples, but also in some negative controls,
suggesting the possibility of general Ljen contamination in the
environment as a possible reason for these results. A potential
drawback of vaginal speciﬁc Lactobacillus markers is, that they are
also detected on body sites close to (female groin) or in contact
with (penis) the vagina, albeit this was tested only in small sample
sizes [46]. The sensitivity was good for all evaluated vaginal
secretion markers. MUC4, HBD1 and Ljen results should be
interpreted carefully because of their cross-reactive potential.
After the commencement of this study, a new vaginal marker
(Mesothelin, MSLN) was described [47]. However, a large sample
to sample variation and some cross reactivity with saliva was
evident. This marker should be subjected to a validation exercise
similar to the one described here to determine whether it offers
superior sensitivity and speciﬁcity in comparison to any of the
tested markers. In summary, most of the evaluated menstrual
blood and vaginal secretion markers proved to be speciﬁc and
sensitive and therefore suitable for forensic stains, even for aged
and low template samples.
Expression analysis of housekeeping genes was evaluated as a
positive control for the presence of biological material and a
successful extraction and reverse transcription of RNA of sufﬁcient
quality and quantity for analysis. The sensitivity of housekeeping
gene detection was in the same range as the body-ﬂuid-speciﬁc
markers [26,39,40] and STR analysis (Table S7), though slightly
reduced in saliva and semen compared to the saliva and semen
speciﬁc markers [40]. Two of the housekeeping genes tested in this
study, B2M and UBC, proved to be quite sensitive and were
detected in most body ﬂuid stains (Table S8). Moreno et al. tested
the expression levels of a selection of housekeeping genes and
showed B2M to be expressed most consistent among body ﬂuids
[48]. Based on our data, these housekeeping genes do not appear to
be particularly good positive controls in the sense that they should
reliably show positive results when biological material is present.
At least for saliva and semen, they are less sensitive than the body
ﬂuid speciﬁc genes. Anyhow, they can be useful for the
interpretation of results together with RNA and DNA data. If for
example, housekeeping gene expression analysis and STR proﬁling
is successful but no body ﬂuid speciﬁc genes are detected, the
biological source material might be another, not tested body ﬂuid
or tissue. If on the other hand STRs can be detected, but no RNA
proﬁling of either housekeeping or body ﬂuid speciﬁc genes were
obtained, sensitivity might be a problem. There is no consensus yet
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ment for RNA based body ﬂuid identiﬁcation assays. More studies
are warranted in this area.
Another issue is the development of suitable interpretation
guidelines, such as those suggested by Lindenbergh et al. [32] or
Roeder et al. [34]. What criteria should one use when considering
the likely presence or absence of a particular ﬂuid, given the
absence/presence and/or relative peak heights of speciﬁc markers?
How many and which markers should at least be present to
identify a body ﬂuid? In general, any false positive reduces the
reliability of a test, therefore further investigations on speciﬁcity
would be useful.
RNA and DNA quantiﬁcation results were reasonably consistent
among laboratories in that high/low input samples could be
differentiated and the dilution series showed a monotonic gradual
decrease in analytical signal. When comparing absolute numbers,
the variation was of course quite high and standard deviations
were in the same range as the mean values. This can easily be
explained by the different extraction and quantiﬁcation methods
used by the laboratories. None of the suggested RNA quantiﬁcation
systems are ideal as they are not human-speciﬁc.
Two laboratories additionally used their own multiplexes (a
19plex from NFI and CellTyper 11plex from ESR) to identify the
stains and dilution series. The results regarding menstrual blood
and vaginal secretion were concordant. No detailed comparisons
with multiplexes were performed since that was not the primary
object of this study.
The following negative controls were included in RNA analysis:
(1) RT minus (no reverse transcriptase added) to identify possible
contaminating DNA (frequently a larger size than the expected
RNA product) or the presence of pseudogenes (same size as RNA
product) and (2) ampliﬁcation blank. In exercise 4, only sporadic
peaks appeared in the RT minus controls and are regarded as
outliers. In exercise 5, eight laboratories found 1, 2 or 3 Lacto peaks
in RT minus controls. This was most probably due to genomic DNA
contamination since 4 of these laboratories did not use the
recommended TURBO DNA-free DNase treatment. In addition, 2
laboratories found Ljen peaks in extraction or PCR negative
controls, which could be due to crosstalk/carryover [49] or a
general Ljen environmental contamination in the laboratory or
contamination of the primer mix.
The possibility of co-extracting RNA and DNA from the same
stain sample is an important operational consideration since the
amount of sample is often limited in forensic casework. From
almost all stains, good quality DNA proﬁles and the positive
identiﬁcation of menstrual blood and vaginal secretion could be
achieved, even for aged stains and those exposed to un-controlled
humidity.
In summary, the results of this study support an RNA/DNA co-
extraction strategy allowing for positive identiﬁcation of the
tissue/ﬂuid source of origin by mRNA proﬁling as well as a
simultaneous identiﬁcation of the body ﬂuid donor by STR
proﬁling. Most of the evaluated menstrual blood and vaginal
secretion markers proved to be robust, reproducible and sensitive.
Care should be taken with the vaginal markers MUC4, HBD1 and
Ljen because of the potential for cross reactivity with other body
ﬂuids as well as presence in negative controls in the case of Ljen.
Co-extracted DNA from the same stain provided good-quality STR
proﬁles. Together with the precedent RNA exercises [38–40], a set
of reliable RNA markers is now available for the identiﬁcation of
the most common forensic body ﬂuids, namely blood, saliva,
semen, menstrual blood and vaginal secretion. A subsequent
EDNAP mRNA exercise will include an evaluation of mRNA
markers for the identiﬁcation of skin. Another task for future
exercises would be the above mentioned development of suitable
interpretation guidelines.Acknowledgements
Special thanks for support and technical assistance to A.M.
Bento (Forensic Genetic and Biology Service, National Institute of
Legal Medicine and Forensic Sciences, Coimbra, Portugal), A.
Carracedo (Institute of Legal Medicine, University of Santiago de
Compostela, Spain), D. Niederwieser (Institute of Legal Medicine,
Innsbruck Medical University, Austria), T. Sijen (Netherlands
Forensic Institute, The Hague, The Netherlands), J. Stacey (Institute
of Environmental Science and Research Ltd., Auckland, New
Zealand) and M. Walt (Institute of Legal Medicine, University of
Zurich, Switzerland).
Appendix A. Supplementary data
Supplementary material related to this article can be found, in
the online version, at doi:10.1016/j.fsigen.2013.09.009.
References
[1] K. Virkler, I.K. Lednev, Analysis of body ﬂuids for forensic purposes: from labora-
tory testing to non-destructive rapid conﬁrmatory identiﬁcation at a crime scene,
Forensic Sci. Int. 188 (2009) 1–17.
[2] T. Akutsu, K. Watanabe, H. Motani, H. Iwase, K. Sakurada, Evaluation of latex
agglutination tests for ﬁbrin–ﬁbrinogen degradation products in the forensic
identiﬁcation of menstrual blood, Leg. Med. (Tokyo) 14 (2012) 51–54.
[3] D.J. Baker, E.A. Grimes, A.J. Hopwood, D-dimer assays for the identiﬁcation of
menstrual blood, Forensic Sci. Int. 212 (2011) 210–214.
[4] M. Bauer, A. Kraus, D. Patzelt, Detection of epithelial cells in dried blood stains by
reverse transcriptase-polymerase chain reaction, J. Forensic Sci. 44 (1999) 1232–
1236.
[5] M. Bauer, D. Patzelt, Evaluation of mRNA markers for the identiﬁcation of
menstrual blood, J. Forensic Sci. 47 (2002) 1278–1282.
[6] M. Bauer, D. Patzelt, A method for simultaneous RNA and DNA isolation from dried
blood and semen stains, Forensic Sci. Int. 136 (2003) 76–78.
[7] M. Bauer, D. Patzelt, Protamine mRNA as molecular marker for spermatozoa in
semen stains, Int. J. Leg. Med. 117 (2003) 175–179.
[8] M. Bauer, S. Polzin, D. Patzelt, Quantiﬁcation of RNA degradation by semi-
quantitative duplex and competitive RT-PCR: a possible indicator of the age of
bloodstains? Forensic Sci. Int. 138 (2003) 94–103.
[9] J. Juusola, J. Ballantyne, Messenger RNA proﬁling: a prototype method to supplant
conventional methods for body ﬂuid identiﬁcation, Forensic Sci. Int. 135 (2003)
85–96.
[10] M. Alvarez, J. Juusola, J. Ballantyne, An mRNA and DNA co-isolation method for
forensic casework samples, Anal. Biochem. 335 (2004) 289–298.
[11] J. Juusola, J. Ballantyne, Multiplex mRNA proﬁling for the identiﬁcation of body
ﬂuids, Forensic Sci. Int. 152 (2005) 1–12.
[12] C. Nussbaumer, E. Gharehbaghi-Schnell, I. Korschineck, Messenger RNA proﬁling:
a novel method for body ﬂuid identiﬁcation by real-time PCR, Forensic Sci. Int.
157 (2006) 181–186.
[13] J. Ballantyne, Validity of messenger RNA expression analyses of human saliva,
Clin. Cancer Res. 13 (2007) 1350, author reply 1351.
[14] M. Bauer, RNA in forensic science, Forensic Sci. Int. Genet. 1 (2007) 69–74.
[15] J. Juusola, J. Ballantyne, mRNA proﬁling for body ﬂuid identiﬁcation by multiplex
quantitative RT-PCR, J. Forensic Sci. 52 (2007) 1252–1262.
[16] M. Bauer, D. Patzelt, Identiﬁcation of menstrual blood by real time RT-PCR:
technical improvements and the practical value of negative test results, Forensic
Sci. Int. 174 (2008) 55–59.
[17] M. Setzer, J. Juusola, J. Ballantyne, Recovery and stability of RNA in vaginal swabs
and blood, semen, and saliva stains, J. Forensic Sci. 53 (2008) 296–305.
[18] D. Zubakov, E. Hanekamp, M. Kokshoorn, W. van Ijcken, M. Kayser, Stable RNA
markers for identiﬁcation of blood and saliva stains revealed from whole genome
expression analysis of time-wise degraded samples, Int. J. Leg. Med. 122 (2008)
135–142.
[19] C. Haas, B. Klesser, C. Maake, W. Bar, A. Kratzer, mRNA proﬁling for body ﬂuid
identiﬁcation by reverse transcription endpoint PCR and realtime PCR, Forensic
Sci. Int. Genet. 3 (2009) 80–88.
[20] C. Haas, C. Muheim, A. Kratzer, W. Ba¨r, C. Maake, mRNA proﬁling for the
identiﬁcation of sperm and seminal plasma, Forensic Sci. Int. Genet. Suppl. Series
2 (2009) 534–535.
[21] C. Cossu, U. Germann, A. Kratzer, W. Ba¨r, C. Haas, How speciﬁc are the vaginal
secretion markers HBD1 and MUC4? Forensic Sci. Int. Genet. Suppl. Series 2
(2009) 536–537.
[22] K. Sakurada, H. Ikegaya, H. Fukushima, T. Akutsu, K. Watanabe, M. Yoshino,
Evaluation of mRNA-based approach for identiﬁcation of saliva and semen,
Leg. Med. (Tokyo) 11 (2009) 125–128.
[23] R.I. Fleming, S. Harbison, The use of bacteria for the identiﬁcation of vaginal
secretions, Forensic Sci. Int. Genet. 4 (2010) 311–315.
C. Haas et al. / Forensic Science International: Genetics 8 (2014) 203–212212[24] R.I. Fleming, S. Harbison, The development of a mRNA multiplex RT-PCR assay for
the deﬁnitive identiﬁcation of body ﬂuids, Forensic Sci. Int. Genet. 4 (2010) 244–
256.
[25] K. Sakurada, T. Akutsu, H. Fukushima, K. Watanabe, M. Yoshino, Detection of
dermcidin for sweat identiﬁcation by real-time RT-PCR and ELISA, Forensic Sci.
Int. 194 (2010) 80–84.
[26] C. Haas, E. Hanson, A. Kratzer, W. Bar, J. Ballantyne, Selection of highly speciﬁc and
sensitive mRNA biomarkers for the identiﬁcation of blood, Forensic Sci. Int. Genet.
5 (2011) 449–458.
[27] K. Sakurada, T. Akutsu, K. Watanabe, Y. Fujinami, M. Yoshino, Expression of
statherin mRNA and protein in nasal and vaginal secretions, Leg. Med. (Tokyo)
13 (2011) 309–313.
[28] T. Takasaka, K. Sakurada, T. Akutsu, K. Nishigaki, H. Ikegaya, Trials of the detection
of semen and vaginal ﬂuid RNA using the genome proﬁling method, Leg. Med.
(Tokyo) 13 (2011) 265–267.
[29] T. Akutsu, H. Motani, K. Watanabe, H. Iwase, K. Sakurada, Detection of bacterial
16S ribosomal RNA genes for forensic identiﬁcation of vaginal ﬂuid, Leg. Med.
(Tokyo) 14 (2012) 160–162.
[30] J.H. An, K.J. Shin, W.I. Yang, H.Y. Lee, Body ﬂuid identiﬁcation in forensics, BMB
Rep. 45 (2012) 545–553.
[31] C. Haas, E. Hanson, J. Ballantyne, Capillary electrophoresis of a multiplex reverse
transcription-polymerase chain reaction to target messenger RNA markers for
body ﬂuid identiﬁcation, Methods Mol. Biol. 830 (2012) 169–183.
[32] A. Lindenbergh, M. de Pagter, G. Ramdayal, M. Visser, D. Zubakov, M. Kayser, T.
Sijen, A multiplex (m)RNA-proﬁling system for the forensic identiﬁcation of body
ﬂuids and contact traces, Forensic Sci. Int. Genet. 6 (2012) 565–577.
[33] M.L. Richard, K.A. Harper, R.L. Craig, A.J. Onorato, J.M. Robertson, J. Donfack,
Evaluation of mRNA marker speciﬁcity for the identiﬁcation of ﬁve human body
ﬂuids by capillary electrophoresis, Forensic Sci. Int. Genet. 6 (2012) 452–460.
[34] A.D. Roeder, C. Haas, mRNA proﬁling using a minimum of ﬁve mRNA markers per
body ﬂuid and a novel scoring method for body ﬂuid identiﬁcation, Int. J. Leg. Med.
127 (2012) 707–721.
[35] F. Kohlmeier, P.M. Schneider, Successful mRNA proﬁling of 23 years old blood
stains, Forensic Sci. Int. Genet. 6 (2012) 274–276.
[36] E.K. Hanson, J. Ballantyne, Highly speciﬁc mRNA biomarkers for the identiﬁcation
of vaginal secretions in sexual assault investigations, Sci. Justice 53 (2013) 14–22.
[37] J. Jakubowska, A. Maciejewska, R. Pawlowski, K.P. Bielawski, mRNA proﬁling for
vaginal ﬂuid and menstrual blood identiﬁcation, Forensic Sci. Int. Genet. 7 (2013)
272–278.
[38] C. Haas, E. Hanson, W. Bar, R. Banemann, A.M. Bento, A. Berti, E. Borges, C.
Bouakaze, A. Carracedo, M. Carvalho, A. Choma, M. Dotsch, M. Duriancikova, P.
Hoff-Olsen, C. Hohoff, P. Johansen, P.A. Lindenbergh, B. Loddenkotter, B. Ludes, O.
Maronas, N. Morling, H. Niederstatter, W. Parson, G. Patel, C. Popielarz, E. Salata,P.M. Schneider, T. Sijen, B. Sviezena, L. Zatkalikova, J. Ballantyne, mRNA proﬁling
for the identiﬁcation of blood – results of a collaborative EDNAP exercise, Forensic
Sci. Int. Genet. 5 (2011) 21–26.
[39] C. Haas, E. Hanson, M.J. Anjos, W. Bar, R. Banemann, A. Berti, E. Borges, C.
Bouakaze, A. Carracedo, M. Carvalho, V. Castella, A. Choma, G. De Cock, M. Dotsch,
P. Hoff-Olsen, P. Johansen, F. Kohlmeier, P.A. Lindenbergh, B. Ludes, O. Maronas, D.
Moore, M.L. Morerod, N. Morling, H. Niederstatter, F. Noel, W. Parson, G. Patel, C.
Popielarz, E. Salata, P.M. Schneider, T. Sijen, B. Sviezena, M. Turanska, L. Zatka-
likova, J. Ballantyne, RNA/DNA co-analysis from blood stains – results of a second
collaborative EDNAP exercise, Forensic Sci. Int. Genet. 6 (2012) 70–80.
[40] C. Haas, E. Hanson, M.J. Anjos, R. Banemann, A. Berti, E. Borges, A. Carracedo, M.
Carvalho, C. Courts, G. De Cock, M. Dotsch, S. Flynn, I. Gomes, C. Hollard, B. Hjort, P.
Hoff-Olsen, K. Hribikova, A. Lindenbergh, B. Ludes, O. Maronas, N. McCallum, D.
Moore, N. Morling, H. Niederstatter, F. Noel, W. Parson, C. Popielarz, C. Rapone,
A.D. Roeder, Y. Ruiz, E. Sauer, P.M. Schneider, T. Sijen, D.S. Court, B. Sviezena, M.
Turanska, A. Vidaki, L. Zatkalikova, J. Ballantyne, RNA/DNA co-analysis from
human saliva and semen stains – results of a third collaborative EDNAP exercise,
Forensic Sci. Int. Genet. 7 (2013) 230–239.
[41] P.J. Smith, J. Ballantyne, Simpliﬁed low-copy-number DNA analysis by post-PCR
puriﬁcation, J. Forensic Sci. 52 (2007) 820–829.
[42] I.S. Fraser, G. McCarron, R. Markham, T. Resta, Blood and total ﬂuid content of
menstrual discharge, Obstetr. Gynecol. 65 (1985) 194–198.
[43] G. Hadzic, A. Lukan, K. Drobnic, Practical value of the marker MUC4 for identiﬁcation
of vaginal secretion in penile swabs, FSI Genet. Suppl. Series 3 (2011) e222–e223.
[44] S. Giampaoli, A. Berti, F. Valeriani, G. Gianfranceschi, A. Piccolella, L. Buggiotti, C.
Rapone, A. Valentini, L. Ripani, V. Romano Spica, Molecular identiﬁcation of
vaginal ﬂuid by microbial signature, Forensic Sci. Int. Genet. 6 (2012) 559–564.
[45] J. Ravel, P. Gajer, Z. Abdo, G.M. Schneider, S.S. Koenig, S.L. McCulle, S. Karlebach, R.
Gorle, J. Russell, C.O. Tacket, R.M. Brotman, C.C. Davis, K. Ault, L. Peralta, L.J.
Forney, Vaginal microbiome of reproductive-age women, Proc. Natl. Acad. Sci.
U.S.A. 108 (Suppl 1) (2011) 4680–4687.
[46] C.C.G. Benschop, F.C.A. Quaak, M.E. Boon, T. Sijen, I. Kuiper, Vaginal microbial ﬂora
analysis by next generation sequencing and microarrays; can microbes indicate
vaginal origin in a forensic context? Int. J. Legal Med. 126 (2012) 303–310.
[47] S.M. Park, S.Y. Park, J.H. Kim, T.W. Kang, J.L. Park, K.M. Woo, J.S. Kim, H.C. Lee, S.Y.
Kim, S.H. Lee, Genome-wide mRNA proﬁling and multiplex quantitative RT-PCR
for forensic body ﬂuid identiﬁcation, Forensic Sci. Int. Genet. 7 (2013) 143–150.
[48] L.I. Moreno, C.M. Tate, E.L. Knott, J.E. McDaniel, S.S. Rogers, B.W. Koons, M.F.
Kavlick, R.L. Craig, J.M. Robertson, Determination of an effective housekeeping
gene for the quantiﬁcation of mRNA for forensic applications, J. Forensic Sci. 57
(2012) 1051–1058.
[49] Maximizing the Performance of Capillary Electrophoresis Systems, Applied Bio-
systems, Forensic News, July (2010).
